Preparing for a New Era: A HER2-low Breast Cancer Implementation Guide 

This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team prepare for the emerging era of “HER2-low” breast cancer. This activity outlines ways to prepare for changes in clinical practice that may be needed as targeted therapies for patients with HER2-low breast cancer begin to emerge. 

Target Audience 

This activity has been designed to meet the educational needs of pathologists, laboratory professionals, and other members of the cancer care team involved in diagnosing patients with breast cancer.    

Activity Agenda 

• Background 

• Definition of “HER2-low” 

• DESTINY-Breast04 

• Anticipating Challenges and Opportunities 

• Conclusion 

Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

Planner/Author

Joseph Kim, MD, MPH, MBA
President
Q Synthesis LLC
Langhorne, PA

Physician Competencies: Patient Care & Procedural Skills, Medical Knowledge, Interpersonal and Communication Skills, Professionalism  

CME/CMLE Credit: 1.0
Estimated Completion Time: 1.0 hour
Format: Online educational activity

Credit Designation Statement

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

ASCP designates this enduring material for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel. 

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time 

Method of Participation

To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line. 

Commercial Support 

Funded by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc. 

Instructions

To claim CME/CMLE credit for the exercise, do the following:

1. Review the Disclosure Information.
2. Review the Technical Considerations.
3. Click Go to Content to view an overview of the modules in this course.
4. Complete the Demographic Survey.
5. Submit the course Evaluation.
6. Enter the number of credits claimed and click Claim CME/CMLE to register credit.

Upon completion of this activity, you will be able to:

• Update laboratory processes and procedures around HER2 classification in breast cancer.  

• Outline ways to improve communication and coordination among pathologists, oncologists, and other members of the cancer care team when discussing HER2 test results in patients with breast cancer.